Cardiovascular risk reduction with empagliflozin: exploring the evidence from EMPA-REG OUTCOME®.
27 August 2017 (13:00 - 13:15)
Organised by:
About the speaker
University of Lorraine, Vandoeuvre-Les-Nancy (France)
6 More presentations in this session
Professor N. Marx (Aachen, DE)
Professor D. McGuire (Dallas, US)
Doctor J. Udell (Toronto, CA)
Professor N. Marx (Aachen, DE)
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Professor D. McGuire (Dallas, US)
Doctor J. Udell (Toronto, CA)
Access the full session
The Event
ESC Congress 2017
27 August 2017
13:00 CET
You may be interested in
Webinar
12 March 2019
Webinar
10 April 2024
Congress Session
